Hirotsugu Uemura

Kindai University

Papers

1

Total Citations

37

H-Index

1

About

Dr. Hirotsugu Uemura is a leading authority in urologic oncology, with a primary focus on bladder cancer management and the development of clinical practice standards. His most significant contribution lies in his leadership of the Japanese Urological Association’s Clinical Practice Guidelines for Bladder Cancer, where he served as a key author on the 2019 revision working position paper. This work, which has garnered 37 citations, reflects his dedication to synthesizing rapidly evolving evidence—from advances in immunotherapy to refined surgical techniques—into actionable frameworks that directly shape patient care across Japan. Beyond guideline development, Dr. Uemura’s research spans the molecular mechanisms of urothelial carcinoma and the optimization of treatment algorithms for both non-muscle-invasive and metastatic disease. His impact is evident in the widespread adoption of these guidelines, which standardize care and improve outcomes for thousands of patients. For students and researchers, Dr. Uemura exemplifies how rigorous clinical scholarship can bridge the gap between cutting-edge research and real-world practice, making him a pivotal figure in the fight against bladder cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
37
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper
37 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Kindai University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago